Loxo Oncology, Inc
LOXO
LOXO was delisted on the 14th of February, 2019.
72 hedge funds and large institutions have $543M invested in Loxo Oncology, Inc in 2016 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 34 increasing their positions, 16 reducing their positions, and 8 closing their positions.
113% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 16
13% more capital invested
Capital invested by funds: $479M → $543M (+$64.2M)
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
1% less funds holding
Funds holding: 73 → 72 (-1)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$42.1M |
| 2 |
PC
Paulson & Co
New York
|
+$12.7M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$8.2M |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$2.88M |
| 5 |
AG
Artal Group
Luxembourg
|
+$1.96M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$13.2M |
| 2 |
O
OrbiMed
New York
|
-$11.7M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
-$3M |
| 4 |
Axa
Paris,
France
|
-$1.61M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.38M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CS
76
Credit Suisse
Zurich,
Switzerland
| – | -$243K | -10,509 | Closed |
|
|
GT
77
Glenmede Trust
Philadelphia,
Pennsylvania
| – | -$2K | -115 | Closed |
|
|
TRCT
78
Tower Research Capital (TRC)
New York
| – | -$2K | -100 | Closed |
|
|
AIM
79
Acrospire Investment Management
Chicago,
Illinois
| – | -$2K | -98 | Closed |
|
80
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$52 | +2 | New |
|
LOXO Hedge Fund Activity: Q3 2016 in Review
72 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q3 2016, worth a combined $543M — up 13% from $479M a quarter earlier.
Fund positioning in LOXO was balanced in Q3 2016: 8 funds opened new positions, 8 closed out, 34 added to existing stakes and 16 trimmed.
The largest buyer was Victory Capital Management, opening a new position worth an estimated $42.1M. The largest seller was NEA Management Company, cutting an estimated $13.2M.
- 72 institutional investors held Loxo Oncology, Inc (LOXO) as of Q3 2016, down from 73 in Q2 2016.
- Funds reported $543M of Loxo Oncology, Inc stock for Q3 2016, up 13% quarter-over-quarter.
- 8 funds opened new Loxo Oncology, Inc positions in Q3 2016 and 8 closed out, a net change of 0 holders.
- The largest Loxo Oncology, Inc buyer in Q3 2016 was Victory Capital Management, an estimated $42.1M added.
- The largest Loxo Oncology, Inc seller in Q3 2016 was NEA Management Company, an estimated $13.2M sold.
Based on aggregated 13F filings for Q3 2016.